
Science Resources RSS Feeds
|
 |
 |
 |
A 'grape' future for Alzheimer's disease research
November 07, 2007
Concord grape juice and red wine polyphenols show promise in counteracting beta-amyloid plaques associated with cognitive decline With National Alzheimer's Awareness Month upon us, attention continues to focus on new approaches to cognitive health in an aging population. Now, research with grape polyphenols presented today at Neuroscience 2007 in San Diego shows promise for maintaining long-term cognitive health. The researchers will now focus on grape polyphenols and Alzheimer's disease (AD) at the newly established Center for Research in Alternative and Complementary Medicine in Alzheimer's disease research at Mount Sinai School of Medicine (MSSM).
Two recent population studies associated moderate red wine and 100 percent fruit juice consumption with lowering the risk of AD dementia (wine) or delay in AD onset (juice). Adding further weight to those studies is the research presented by Dr. Lap Ho at Neuroscience 2007, which demonstrated the potentially protective effect of Concord grape juice and Cabernet Sauvignon polyphenols to slow beta-amyloid neuropathology.
A characteristic hallmark of Alzheimer's disease-type neuropathology is the accumulation of beta-amyloid peptides and their formation into plaques in the brain. Dr. Ho at MSSM found that polyphenol extracts from Cabernet Sauvignon and Concord grape juice reduced the generation and accumulation of beta-amyloid peptides in experimental models of Alzheimer's disease.
"This grape polyphenol research is preliminary, but very encouraging," said Dr. Giulio Pasinetti, director of the new center and principal investigator of the research program in polyphenolics at MSSM. "The results show the potential protective role which non-alcoholic, polyphenol-rich Concord grape juice may play in maintaining long term cognitive health."
Previous work by Dr. Pasinetti's group at MSSM reported that moderate consumption of Cabernet Sauvignon wine had reduced AD-type neuropathology and prevented cognitive decline in a transgenic mouse model , yet counseled that even moderate intake of alcohol may carry health risks, particularly with an older population.
Currently, it is estimated that five million people in the United States suffer from Alzheimer's disease, with the number projected to reach 11 to 16 million by the year 2050. However, delaying the onset of Alzheimer's disease by five years is estimated to potentially reduce the number of projected cases by 50 percent. Ongoing studies directed by Dr. Pasinetti at the new center will provide critical information about the functional role of selected grape-derived polyphenols in the prevention and/or attenuation of cognitive deterioration of Alzheimer's disease.
"Our goal is to learn which compounds are bioactively available to reach the brain and exert a benefit," says Dr. Pasinetti.
Hunter Public Relations
|
 |

|
Pharmacogenomics in Drug Discovery and Development (Methods in Molecular Biology)
by Qing Yan (Editor)
Since each human is genetically distinctive, responding differently to disease-causing factors as well as drugs, the field pharmacogenomics arose to develop personalized medicine, or medicine that deals with the complexity of the human body. In Pharmacogenomics in Drug Discovery and Development, leading experts present methodical, state-of-the-art contributions covering topics from individual molecules to systemic diseases, examining both fundamental concepts and advanced technologies. Divided into three sections, the volume begins by exploring cutting-edge technologies used to pursue systems-based pharmacogenomics, followed by extensive chapters on gene-drug interactions and the use of pharmacogenomics in therapeutics of diseases. Comprehensive and up-to-date, Pharmacogenomics...
|

|
New Science of Alzheimer's Disease / TIME Cover: July 17, 2000, Framed Art Print by TIME Magazine
by barewalls
The most eagerly awaited event in the editorial cycle at TIME Magazine is always the selection of the cover. The best covers capture the zeitgeist of the week while surviving the judgment of history. As browsing this collection of TIME cover art prints shows, TIME is as good a record as any of who and what mattered over the past 80-plus years. And so when TIME captures a person, an event or a trend within its iconic red borders, the magazine is adding that extra dose of significance that no other publication can quite match. That is one reason why the original artwork for more than 800 TIME covers now resides in the National Portrait Gallery in Washington. Thanks to an amazing roster of artists, photographers and graphic designers, from TIME's earliest charcoal drawings of cover subjects...
|

|
The Forgetting - A Portrait of Alzheimer's
Starring: David Hyde Pierce Directed By: Elizabeth Arledge Also With: Elizabeth Arledge (Producer), Doug Quade (Editor), Naomi S. Boak (Producer), Whitney Johnson (Producer)
Studio: Paramount Home Video Release Date: 11/01/2005
|

|
Lappare Foti Root Shampoo with Lavender & Menthol (8oz)
by EMPIRE VITAMINS INC
FO-TI has been used by Chinese over the years. Many people are taking FO-TI and they have observed that their hair is getting darker. It also helps for faster growth of the hair besides making it less gray.The hair is composed of proteins. The melanin in the hair is in charge for the color of the hair. The amount of melanin that is present is responsible for the various colors of the hair. The darker the hair color, the more the melanin content. As people age, the quantity of the melanin in the hair reduces. This causes the hair to become gray and at some point becomes color white. Having a balance diet and sufficient nutrients can help slow down the graying effect on the hair. FO-TI is a herbal plant that can be useful in preventing the graying of the hair when used in shampoos.
|

|
Alzheimer's Disease: A Wilderness Exposed (NCME Video S103)
Also With: Network For Continuing Medical Education (Primary Contributor), Kenneth L. David (Primary Contributor), Allen D. Roses (Primary Contributor), Dennis J. Selkoe (Primary Contributor), Rudolph E. Tanzi (Primary Contributor)
|

|
Natrol Extra Strength ENADA NADH, 5 mg, MicroTablets - 30 ea
by Natrol
The Energizing CoEnzyme. A Patented Formula. The Only Stable NADH. Maximum Bioavailability. Dietary Supplement. Natrol® Enada®'s NADH is a patented dietary ingredient designed for those whose active lifestyles demand the very best. As a coenzyme, NADH plays a key role in the energy production of our cells and neurotransmitter processes.* Natrol offers Enada's NADH - the only stable form of NADH in the marketplace today. This exclusive patented supplement assures maximum bioavailability. *The FDA has not evaluated this statement. This product is not intended to diagnose, treat, cure or prevent disease. If you have or suspect a medical condition, consult your healthcare professional prior to use. NADH (Vegetable source) (reduced 5 nicotinamide...
|

|
The Inflammation Pathway from Cholesterol to Aging - Medications and Plants that prevent and treat Aging, Cardiovascular Disease, Osteoporosis, Arthritis, Type-2 Diabetes, Dementia and Alzheimers disease
by Sota Omoigui MD (Author)
|

|
Mayo Clinic on Alzheimers Disease
by M.D., Ph.D. Ronald Petersen (Editor)
|
|
|
Alzheimer's s Disease: An Overview.: An article from: Southern Medical Journal
by Ronald C. Hamdy (Author)
This digital document is an article from Southern Medical Journal, published by Southern Medical Association on July 1, 2001. The length of the article is 1102 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details Title: Alzheimer's s Disease: An Overview. Author: Ronald C. Hamdy Publication: Southern Medical Journal (Refereed) Date: July 1, 2001 Publisher: Southern Medical Association Volume: 94 Issue: 7 Page: 661
Distributed by Thomson...
|

|
A Guide to the Spiritual Dimension of Care for People With Alzheimer s Disease and Related Dementia: More Than Body, Brain, and Breath
by Eileen Shamy (Author)
In this sensitive and informative book, Eileen Shamy, a pioneer of ministry to people with Alzheimer's disease, discusses how pastoral work can help to develop holistic care for those suffering from dementia and related conditions - care which involves understanding of their spiritual as well as physical needs. From her years of experience as a clergywoman working with older people in care settings, the author provides guidelines for pastoral visits to people with dementia, showing how to empathise with, understand and support individuals during a visit. She discusses what constitutes spiritual well-being in individuals and suggests ways in which this can be nurtured. Emphasising the importance of retaining dignity and freedom of choice for people with dementia, she also presents...
|
|